TY - JOUR
T1 - Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease
AU - Paul, Timir K.
AU - Mamas, Mamas A.
AU - Shanmugasundaram, Madhan
AU - Nagarajarao, Harsha S.
AU - Ojha, Chandra P.
AU - Jneid, Hani
AU - Kumar, Gautam
AU - White, Christopher J.
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.
PY - 2021/4
Y1 - 2021/4
N2 - Purpose of Review: This article reviews the evidence on optimal medical therapy (OMT) versus coronary revascularization in patients with stable ischemic heart disease (SIHD) and advanced chronic kidney disease (CKD). Recent Findings: A post hoc analysis of the COURAGE trial in patients with SIHD and CKD showed no difference in freedom from angina, death, and nonfatal myocardial infarction (MI) between OMT and percutaneous intervention plus OMT compared with patients without CKD. The ISCHEMIA-CKD trial of 777 patients with advanced CKD revealed no difference in cumulative incidence of death or nonfatal MI at 3 years between OMT and revascularization but the composite of death or new dialysis was higher in the invasive arm. Additionally, there were no significant or sustained benefits in related to angina-related health status in invasive versus conservative strategy. Summary: An initial revascularization strategy does not reduce mortality or MI or relieve angina symptoms in patients with SIHD and advanced CKD.
AB - Purpose of Review: This article reviews the evidence on optimal medical therapy (OMT) versus coronary revascularization in patients with stable ischemic heart disease (SIHD) and advanced chronic kidney disease (CKD). Recent Findings: A post hoc analysis of the COURAGE trial in patients with SIHD and CKD showed no difference in freedom from angina, death, and nonfatal myocardial infarction (MI) between OMT and percutaneous intervention plus OMT compared with patients without CKD. The ISCHEMIA-CKD trial of 777 patients with advanced CKD revealed no difference in cumulative incidence of death or nonfatal MI at 3 years between OMT and revascularization but the composite of death or new dialysis was higher in the invasive arm. Additionally, there were no significant or sustained benefits in related to angina-related health status in invasive versus conservative strategy. Summary: An initial revascularization strategy does not reduce mortality or MI or relieve angina symptoms in patients with SIHD and advanced CKD.
KW - Advanced chronic kidney disease
KW - Coronary artery bypass graft
KW - Optimal medical therapy
KW - Percutaneous coronary intervention
KW - Revascularization
KW - Stable ischemic heart disease
UR - http://www.scopus.com/inward/record.url?scp=85102073995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102073995&partnerID=8YFLogxK
U2 - 10.1007/s11886-021-01453-y
DO - 10.1007/s11886-021-01453-y
M3 - Review article
C2 - 33655382
AN - SCOPUS:85102073995
SN - 1523-3782
VL - 23
JO - Current Cardiology Reports
JF - Current Cardiology Reports
IS - 4
M1 - 23
ER -